Posted in Clinical Data ACC 2026: dulaglutide promotes coronary plaque stabilisation in patients with T2D April 1, 2026 Pharmaceutical Technology Data presented at ACC 2026 suggests that dulaglutide may be stabilising coronary plaques from the inside out, as well as managing diabetes. Clinical DataCardiovascularRead full story